TRUMP’S NEW FDA HEAD TARGETS REGULATIONS, ADVOCATE OF UNCONTROLLED AND DANGEROUS EXPERIMENTATION ON US POPULATION


From Bloomberg

Workers in the FDA’s Office of Regulatory Affairs will begin focusing on overseeing specific product areas — such as pharmaceuticals or medical devices — rather than activities in their U.S. geographic regions, Gottlieb said Monday in a memo obtained by Bloomberg News. The staff of 4,000 investigates consumer complaints, oversees imported goods, and inspects domestic and foreign facilities to ensure compliance with agency standards. The initiative was proposed four years ago, with implementation set to start this month.

https://www.bloomberg.com/news/articles/2017-05-15/new-fda-commissioner-gottlieb-reorganizing-inspection-staff

Comments are closed.

%d bloggers like this: